Jae-Hyun Hong
Algemeen Directeur bij SINIL PHARMACEUTICAL CO., LTD.
Vermogen: 12 M $ op 31-05-2024
Profiel
Jae-Hyun Hong is currently the President, Chief Executive Officer & Director at SINIL PHARMACEUTICAL Co., Ltd.
She is also an Investment Manager at DSC Investment, Inc. (Venture Capital).
Ms. Hong holds an MBA from Korea University and an undergraduate degree from Dongduk Women's University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-12-2023 | 2 406 364 ( 20.08% ) | 12 M $ | 31-05-2024 |
Actieve functies van Jae-Hyun Hong
| Bedrijven | Functie | Begin |
|---|---|---|
| SINIL PHARMACEUTICAL CO., LTD. | Algemeen Directeur | 01-01-2000 |
DSC Investment, Inc. (Venture Capital)
 DSC Investment, Inc. (Venture Capital) Investment ManagersFinance DSC Investment, Inc. (Venture Capital) (DSC Investment) is the operating venture capital division of DSC Investment, Inc. The firm was founded in 2012 and is headquartered in Seoul, South Korea. | Private Equity Investor | - |
Opleiding van Jae-Hyun Hong
| Dongduk Women's University | Undergraduate Degree |
| Korea University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| SINIL PHARMACEUTICAL Co., Ltd. | |
DSC Investment, Inc. (Venture Capital)
DSC Investment, Inc. (Venture Capital) Investment ManagersFinance DSC Investment, Inc. (Venture Capital) (DSC Investment) is the operating venture capital division of DSC Investment, Inc. The firm was founded in 2012 and is headquartered in Seoul, South Korea. | Finance |
